Neuroscience
Positron Emission Tomography
100%
Glutamic Acid
96%
Antipsychotic
86%
Cannabinoid 1 Receptor
74%
positron emission tomographic scan
61%
Meta-Analysis
61%
Fluorine-18
42%
Hippocampus
35%
In Vivo
29%
Receptor
29%
Functional Magnetic Resonance Imaging
27%
Working Memory
25%
Anterior Cingulate Cortex
24%
Nuclear Magnetic Resonance Spectroscopy
24%
Brain Imaging
24%
Tetrahydrocannabinol
21%
Negative Syndrome
20%
Placebo
20%
Endocannabinoid System
19%
Positive Syndrome
18%
Striatum
17%
Cannabis
16%
Metabolic Pathway
15%
Endocannabinoid
15%
Ketamine
14%
Dopaminergic
14%
Blood Plasma
14%
Bipolar Disorder
12%
Body Mass Index
12%
Shaw Potassium Channel
12%
Nerve Potential
12%
Gamma-Aminobutyric Acid
12%
Dextro Aspartic Acid
12%
Memory
12%
Diffusion MRI
12%
GABAA Receptor
12%
Ro15-4513
12%
Aspartic Acid
12%
Agonist
9%
Thalamus
8%
Cannabinoid
8%
Blood-Oxygen-Level Dependent
8%
Comorbidity
8%
Oleoylethanolamide
8%
Frontal Lobe
7%
Temporal Lobe
6%
Schizoaffective Disorder
6%
Nucleus Accumbens
6%
Single-Photon Emission Computed Tomography
6%
Saturated Fatty Acid
6%
Medicine and Dentistry
Polyethylene Terephthalate
38%
Meta-Analysis
36%
Systematic Review
36%
Glutamic Acid
24%
Diseases
21%
Volunteer
18%
Anterior Cingulate
17%
Dopamine Metabolism
17%
Antipsychotic
17%
Placebo
16%
Cingulate Cortex
16%
Fluorine-18
16%
Functional Magnetic Resonance Imaging
15%
Ketamine
14%
Proton Nuclear Magnetic Resonance
13%
N Methyl-D-Aspartate Receptor
12%
Psychiatry
12%
Working Memory
12%
Brain Imaging
12%
Body Mass Index
12%
Nerve Potential
12%
Cannabis
12%
Therapeutic Use
12%
Shaw Potassium Channel
12%
Diffusion MRI
12%
Tetrahydrocannabinol
12%
Channel Modulator
12%
Positron Emission Tomography
9%
Effect Size
8%
Volume of Distribution
8%
Chronicity
7%
Blood-Oxygen-Level Dependent
7%
Pathophysiology
6%
Positive and Negative Syndrome Scale
6%
Brain Region
6%
Saturated Fatty Acid
6%
Nucleus Accumbens
6%
Negative Syndrome
5%
Brief Psychiatric Rating Scale
5%
Pharmacology, Toxicology and Pharmaceutical Science
Cannabinoid 1 Receptor
36%
Polyethylene Terephthalate
36%
Tetrahydrocannabinol
24%
Cannabis
19%
Comorbidity
18%
Endocannabinoid System
17%
Placebo
13%
Therapeutic Use
12%
Ketamine
12%
Glutamic Acid
12%
Triacylglycerol
12%
Carbon 11
12%
Tracer
10%
Negative Syndrome
8%
Diseases
8%
Positive Syndrome
8%
Cannabinoid
6%
Endocannabinoid
6%
Normal Human
5%
Receptor
5%
Pathophysiology
5%